文献速递消化道肿瘤放疗放疗物理与技术

计划危及器官体积边界与配准方法对局部晚期胰腺导管腺癌中度大分割IMRT晚期胃肠道毒性的影响

Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma.
PubMed 文献 · Radiat Oncol · 2023-06-19

本研究回顾性分析了37例局部晚期胰腺导管腺癌患者接受中度大分割IMRT的资料,比较宽PRV边界联合软组织配准(方案A,23例)与窄PRV边界联合金标配准(方案B,14例)对晚期胃肠道毒性、局部控制率和总生存率的影响,并评估每日剂量偏差原因。结果显示方案B的3-4级晚期胃肠道毒性发生率高于方案A,2年局部控制率方案B显著高于方案A,总生存率无显著差异。

要点

  • 方案B(窄PRV边界联合金标配准)的3-4级晚期胃肠道毒性发生率为42.9%,高于方案A的4.3%。
  • 方案B的2年局部控制率为90.0%,显著高于方案A的33.3%,但两方案总生存率无显著差异。
  • 每日剂量评估显示,方案B中胃至十二指肠球部V3 Gy每次分次的偏差频率为44.8%,显著高于方案A的24.3%。

核心结论

  • 缩小PRV边界并采用金标配准虽提高了局部控制率,但增加了胃肠道毒性,每日剂量分析表明GTV剂量覆盖与胃肠道受照剂量之间存在权衡。
  • 即使采用严格配准方法,由于胃肠道分次间误差,PRV边界仍无法安全缩小,该问题有望通过在线自适应放疗解决。

研究设计与样本

  • 回顾性研究,纳入2016年至2020年在本机构接受中度大分割IMRT的37例局部晚期胰腺导管腺癌患者。
  • 23例接受宽PRV边界联合软组织配准(方案A),14例接受窄PRV边界联合金标配准(方案B)。
  • 评估各方案的胃肠道毒性、局部控制率和总生存率,并基于锥形束CT重建初始计划剂量和每日剂量至GTV、胃和十二指肠。

主要发现

  • 方案B的3-4级晚期胃肠道毒性发生率为42.9%,高于方案A的4.3%。
  • 方案B的2年局部控制率为90.0%,显著高于方案A的33.3%,但总生存率无显著差异。
  • 初始计划中,两方案的胃和十二指肠剂量均未偏离剂量约束。
  • 每日剂量评估显示,方案B中胃至十二指肠球部V3 Gy每次分次的偏差频率为44.8%,显著高于方案A的24.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study examined the differences in late gastrointestinal (GI) toxicities in moderately hypofractionated intensity-modulated radiation therapy (IMRT) for locally advanced pancreatic ductal adenocarcinoma (LA-PDAC) by changing the planning organs at risk volume (PRV) margin and the target matching method and assessed the causes of adverse events. METHODS: We examined 37 patients with LA-PDAC who underwent moderately hypofractionated IMRT between 2016 and 2020 at our institution; 23 patients were treated with wide PRV margins and soft tissue matching (Protocol A) and 14 with narrow PRV margins and fiducial marker matching (Protocol B). The GI toxicities, local control (LC) rate, and overall survival (OS) were assessed for each protocol. The initially planned and daily doses to the gross tumor volume (GTV), stomach, and duodenum, reproduced from cone-beam computed tomography, were evaluated. RESULTS: The late GI toxicity rate of grades 3-4 was higher in Protocol B (42.9%) than in Protocol A (4.3%). Although the 2-year LC rates were significantly higher in Protocol B (90.0%) than in Protocol A (33.3%), no significant difference was observed in OS rates. In the initial plan, no deviations were found for the stomach and duodenum from the dose constraints in either protocol. In contrast, daily dose evaluation for the stomach to duodenal bulb revealed that the frequency of deviation of V3 Gy per session was 44.8% in Protocol B, which was significantly higher than the 24.3% in Protocol A. CONCLUSIONS: Reducing PRV margins with fiducial marker matching increased GI toxicities in exchange for improved LC. Daily dose analysis indicated the trade-off between the GTV dose coverage and the irradiated doses to the GI. This study showed that even with strict matching methods, the PRV margin could not be reduced safely because of GI inter-fractional error, which is expected to be resolved with online adaptive radiotherapy.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ogawa A, Yoshimura M, Nakamura M, et al. Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma. Radiat Oncol. 2023. PMID: 37337247. doi:10.1186/s13014-023-02288-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。